Literature DB >> 6621540

Interaction of C3 and C3b with immunoglobulin G.

J Kulics, E Rajnavölgyi, G Füst, J Gergely.   

Abstract

Human C3b as well as native C3 were found to bind to solid phase human and rabbit IgG. Haemolytically active C3 had significantly higher binding capacity to IgG than the C3b fragment. Inhibition experiments proved that C3 and C3b have common binding sites on the Fab and Fc part of the IgG molecule but the character of these binding sites was different. As a functional consequence of C3-IgG interaction, C3 binding was found to inhibit the specific precipitation of an IgG antibody preparation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6621540     DOI: 10.1016/0161-5890(83)90076-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.

Authors:  E Jelezarova; A Vogt; H U Lutz
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation.

Authors:  Hans U Lutz; Peter J Späth
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Interactions of monomeric IgG bearing covalently bound C3b with polymorphonuclear leucocytes.

Authors:  A Malbran; M M Frank; L F Fries
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

4.  Naturally occurring anti-band 3 antibodies have a unique affinity for C3.

Authors:  H U Lutz; M Nater; P Stammler
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

5.  Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.

Authors:  M Basta; P Kirshbom; M M Frank; L F Fries
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.

Authors:  L F Fries; T A Gaither; C H Hammer; M M Frank
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.